Don’t Miss Out: Step-By-Step Guide To Check Jaro Institute IPO Allotment Status

Updated: September 26, 2025 11:31

Image Source : IPO

Jaro Institute of Technology Management & Research Ltd’s IPO allotment is anticipated to be finalized on Friday, September 26, 2025. Investors who participated in the public issue can soon check their allotment status as the stock gears up for a listing on the NSE and BSE scheduled for September 30, 2025.

IPO Subscription Snapshot

The Rs 450 crore IPO had a price band of Rs 846-890 per share, with a lot size of 16 shares.
The issue was oversubscribed 23.20 times according to NSE data, demonstrating strong investor interest.
Qualified Institutional Buyers (QIBs) led the charge with a subscription rate of 37.19 times, followed closely by Non-Institutional Investors (NIIs) at 37.32 times. Retail investors participated at a healthy 9.15 times subscription.
The IPO combined a fresh issue of 0.19 crore shares (approximately Rs 170 crore) and an Offer For Sale (OFS) of 0.31 crore shares (around Rs 280 crore).

How To Check Allotment Status

Investors can verify their allotment status conveniently online by visiting:
The registrar’s official website - Bigshare Services Private Limited
The NSE or BSE IPO allotment status pages

Call for Details: Subscribers may need their PAN card or application number to access allotment details. This step confirms the number of shares allocated against a bid.

Latest Grey Market Premium (GMP) Insights

The grey market premium stood at Rs 73 per share as of September 26, reflecting positive listing sentiments.
Based on GMP, the estimated listing price is around Rs 963, translating to an approximate 8.2% gain from the upper price band.
These figures are indicative only and may vary based on market dynamics closer to the listing date.

What’s Next

Refunds for unallotted shares are expected soon after allotment finalization, with credit of shares to demat accounts following immediately. The listing on NSE and BSE is scheduled for September 30, 2025, and market watchers anticipate a strong debut given the IPO’s robust subscription and GMP.

Sources: NSE India, Bigshare Services, Economic Times, Groww, Moneycontrol

Stay Ahead – Explore Now! Infinium Pharmachem Inks 5-Year Japan Deal with K Sakai & Co.—Eyes Global Iodine Expansion